title: Genotype to phenotype correlations in mitochondrial encephalomyopathies associated with the A3243G mutation of mitochondrial DNA.
abstract: We studied 22 subjects carrying the A3243G point mutation of human mitochondrial DNA (mtDNA). In 14 cases the clinical phenotype was characterized by mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS), while 8 patients had chronic progressive external ophthalmoplegia (CPEO). The proportion of A3243G heteroplasmy in muscle was determined by two methods; densitometry on a diagnostic restriction-fragment length polymorphism and solid-phase mini-sequencing. We found a highly significant inverse correlation between the percentage of A3243G mutation and the specific activity of complex I, the respiratory complex with the highest number of mtDNA-encoded subunits, suggesting a direct effect of the mutation on mtDNA translation. No correlation was observed between the percentage of mutated mtDNA and the presence or absence of specific clinical features, such as stroke, ophthalmoplegia and diabetes mellitus. However, in the MELAS group the percentage of mutated mtDNA molecules was strongly correlated with the age of onset, while no such correlation was found in the CPEO group, suggesting a different time-dependent evolution of the mutation in the two groups. Finally, in contrast with other mtDNA mutations associated with ragged-red fibres (RRF), in both MELAS3243 and CPEO3243 we observed a high proportion of RRF that were positive to the histochemical reaction to cytochrome c oxidase, a morphological feature that seems to be specific for the neuromuscular phenotypes associated with mutations affecting the tRNA(Leu(UUR)) gene.
authors.affiliation: Istituto Nazionale Neurologico Carlo Besta, Divisione di Biochimica e Genetica, Milan, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Mariotti
authors.forename: N
authors.initials: N
authors.lastname: Savarese
authors.forename: A
authors.initials: A
authors.lastname: Suomalainen
authors.forename: M
authors.initials: M
authors.lastname: Rimoldi
authors.forename: G
authors.initials: G
authors.lastname: Comi
authors.forename: A
authors.initials: A
authors.lastname: Prelle
authors.forename: C
authors.initials: C
authors.lastname: Antozzi
authors.forename: S
authors.initials: S
authors.lastname: Servidei
authors.forename: L
authors.initials: L
authors.lastname: Jarre
authors.forename: S
authors.initials: S
authors.lastname: DiDonato
authors.forename: M
authors.initials: M
authors.lastname: Zeviani
mesh_terms: D000293:Adolescent; D000328:Adult; D001483:Base Sequence; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D004272:DNA, Mitochondrial / Q000235:genetics*; D005260:Female; D005838:Genotype; D006801:Humans; D007223:Infant; D017241:MELAS Syndrome / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D017246:Ophthalmoplegia, Chronic Progressive External / Q000235:genetics*; D010085:Oxidative Phosphorylation; D010641:Phenotype; D017354:Point Mutation; D012150:Polymorphism, Restriction Fragment Length; D012356:RNA, Transfer, Leu / Q000235:genetics*
chemical_list: D004272:DNA, Mitochondrial; D012356:RNA, Transfer, Leu